TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16114784

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg t.i.d.
Number of subjects: 130

Group type: COMPARATOR
Intervention: Captopril 25 mg t.i.d.
Number of subjects: 130
Study: 10517426

Group type: EXPERIMENTAL
Intervention: Oral oseltamivir (100 mg once daily, 100 mg twice daily)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Combined oseltamivir groups (n = 56)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Oseltamivir treatment
Number of subjects: 117
Study: 7862369

Group type: EXPERIMENTAL
Intervention: Blood transfusions during surgery or within 30 days
Number of subjects: 265

Group type: COMPARATOR
Intervention: No blood transfusions
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Blood transfusions
Number of subjects: 265
Study: 2285620

Group type: EXPERIMENTAL
Intervention: Porcine heparin
Number of subjects: 113

Group type: COMPARATOR
Intervention: Bovine heparin
Number of subjects: 113
Study: 7363796

Group type: EXPERIMENTAL
Intervention: 750 mg of quinidine bisulphate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Quinidine treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Quinidine and digitoxin therapy
Number of subjects: 10
Study: 30688760

Group type: EXPERIMENTAL
Intervention: Mindfulness-based group cognitive behavior therapy (M-gCBT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Education support group therapy
Number of subjects: 31
Study: 27803960

Group type: EXPERIMENTAL
Intervention: Radiosurgery (RS)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Fractionated stereotactic radiotherapy (FSRT)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Radiosurgery (RS) vs. Fractionated stereotactic radiotherapy (FSRT)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Overall survival (OS) after RT
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Progression-free survival (PFS)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Patient survey outcomes
Number of subjects: 184
Study: 25043337

Group type: EXPERIMENTAL
Intervention: RBP-7000 at 60 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: RBP-7000 at 90 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: RBP-7000
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: RBP-7000 at 60 mg and 90 mg
Number of subjects: 90
Study: 22932339

Group type: EXPERIMENTAL
Intervention: GSK1034702 (8 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 21455123

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate (LC) diet
Number of subjects: 81

Group type: COMPARATOR
Intervention: Low-fat (LF) diet
Number of subjects: 81
Study: 18996011

Group type: EXPERIMENTAL
Intervention: Visual feedback magnification at 1 x, 4 x, 8 x, 16 x, 32 x, 48 x, and 64 x on a non-compliant surface
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual feedback magnification at 1 x, 4 x, 8 x, 16 x, 32 x, 48 x, and 64 x on a foam surface
Number of subjects: 0
Study: 17598697

Group type: EXPERIMENTAL
Intervention: Melcam 15 mg tablets (test preparation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference preparation tablets
Number of subjects: 24
Study: 15010183

Group type: EXPERIMENTAL
Intervention: Modafinil (1.75, 3.5, or 7.0 mg/kg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Amphetamine (0.035, 0.07, 0.14 mg/kg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 11558030

Group type: EXPERIMENTAL
Intervention: Prednisone (40 mg)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Allopurinol (200 mg)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 9549736

Group type: EXPERIMENTAL
Intervention: Midazolam 0.5 mg.kg‐1 (maximum 10 mg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 7835358

Group type: EXPERIMENTAL
Intervention: AAIR or DDDR pacing
Number of subjects: 15

Group type: COMPARATOR
Intervention: VVIR pacing
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: DDDR pacing
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: AAIR pacing
Number of subjects: 15
Study: 31414613

Group type: EXPERIMENTAL
Intervention: Hashimoto's thyroiditis group
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 29274396

Group type: EXPERIMENTAL
Intervention: Treosulfan/Fludarabine with 2 Gy Total Body Irradiation (TBI)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Treosulfan/Fludarabine without Total Body Irradiation (non-TBI)
Number of subjects: 100
Study: 28438414

Group type: EXPERIMENTAL
Intervention: BLTR (bilamellar tarsal rotation)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: PLTR (posterior lamellar tarsal rotation)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Both PLTR and BLTR
Number of subjects: 1000
Study: 26182779

Group type: EXPERIMENTAL
Intervention: Single session oesophageal variceal band ligation (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Multi-session oesophageal variceal band ligation (group A)
Number of subjects: 60
Study: 23571785

Group type: EXPERIMENTAL
Intervention: Pimecrolimus (PIM) cream
Number of subjects: 15

Group type: COMPARATOR
Intervention: Triamcinolone acetonide cream (TA)
Number of subjects: 15
Study: 21345423

Group type: EXPERIMENTAL
Intervention: MMR protocol (preoperative education, early feeding, and mobilisation)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: MMR protocol
Number of subjects: 119

Group type: COMPARATOR
Intervention: Traditional model
Number of subjects: 119
Study: 18384552

Group type: EXPERIMENTAL
Intervention: 3% tetracycline 0.1% triamcinolone acetonide
Number of subjects: 44

Group type: COMPARATOR
Intervention: 0.1% triamcinolone acetonide
Number of subjects: 44
Study: 16818033

Group type: EXPERIMENTAL
Intervention: Testicular tissue biopsies for sperm extraction
Number of subjects: 35
Study: 14524485

Group type: EXPERIMENTAL
Intervention: Cranberry juice (354 ml/day)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Apple juice (354 ml/day)
Number of subjects: 112
Study: 10738956

Group type: EXPERIMENTAL
Intervention: Posting signs in men's bathrooms
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Removal of signs
Number of subjects: 6
Study: 8766671

Group type: EXPERIMENTAL
Intervention: Soya formula (group A)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Hydrolysate of soya and bovine collagen (group B)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Hydrolysate of casein (group C)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 55
Study: 1410946

Group type: EXPERIMENTAL
Intervention: Manual treatment (manipulation, specific mobilization, muscle stretching, auto-traction, cortisone injections)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Conventional treatment (standardized conventional but optimal activating treatment by primary health care teams)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Manual treatment
Number of subjects: 101
Study: 2412056

Group type: COMPARATOR
Intervention: Ketanserin, a serotonergic antagonist, administered for 5 days.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single oral dose of Ketanserin.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ketanserin (in vitro).
Number of subjects: 0
Study: 29576307

Group type: EXPERIMENTAL
Intervention: MenACWY-TT vaccine (1 and 2 doses)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: MenACWY-TT vaccine (2 doses)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (healthy participants)
Number of subjects: 80
Study: 26903486

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle warm-up (IMW)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (IMWp)
Number of subjects: 26
Study: 24972402

Group type: EXPERIMENTAL
Intervention: 2-week placement in aged care facilities
Number of subjects: 30
Study: 22438232

Group type: EXPERIMENTAL
Intervention: Ciclesonide (507 μg/d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (202 μg/d)
Number of subjects: 100
Study: 20442101

Group type: EXPERIMENTAL
Intervention: Calcium hydroxylapatite (Radiesse)
Number of subjects: 102
Study: 18671773

Group type: EXPERIMENTAL
Intervention: Oral prednisone and intranasal budesonide for 2 weeks, plus intranasal budesonide for 10 additional weeks
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (not treated with glucocorticoids)
Number of subjects: 65
Study: 15757851

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) treatment in patients with OH
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Levothyroxine (LT4) treatment in patients with SH
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (euthyroid)
Number of subjects: 45
Study: 12477601

Group type: EXPERIMENTAL
Intervention: THC 0.15 mg/min
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: THC 0.25 mg/min
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: THC (both doses)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: THC (high dose)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: THC
Number of subjects: 47
Study: 10037559

Group type: EXPERIMENTAL
Intervention: Corneal temperature
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Corrected mean corneal temperature in males
Number of subjects: 266
Study: 7745508

Group type: COMPARATOR
Intervention: One dose of synthetic surfactant
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Three doses of synthetic surfactant
Number of subjects: 826
Study: 2291059

Group type: EXPERIMENTAL
Intervention: Percutacrine Oestrogénique
Number of subjects: 121

Group type: COMPARATOR
Intervention: Parlodel
Number of subjects: 121
Study: 6986110

Group type: EXPERIMENTAL
Intervention: Inhalant solution of metaproterenol
Number of subjects: 22

Group type: COMPARATOR
Intervention: 0.5% solution of isoproterenol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31430688

Group type: EXPERIMENTAL
Intervention: Individual cognitive‐behavioral therapy (CBT)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Group cognitive‐behavioral therapy (CBT)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR)
Number of subjects: 168
Study: 28073322

Group type: EXPERIMENTAL
Intervention: Group-focused cognitive-behavioral coaching program
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 26853210

Group type: EXPERIMENTAL
Intervention: Experiencing racism in the past year (measured by the Measure of Indigenous Racism Experience)
Number of subjects: 541

Group type: COMPARATOR
Intervention: Not experiencing racism
Number of subjects: 541
Study: 24720928

Group type: EXPERIMENTAL
Intervention: Fatigue score 3-4 (n = 1,663)
Number of subjects: 3830

Group type: COMPARATOR
Intervention: Fatigue score 0-1 (n = 535)
Number of subjects: 3830

Group type: EXPERIMENTAL
Intervention: Dyspnea score 3-4 (n = 1,843)
Number of subjects: 3830

Group type: COMPARATOR
Intervention: Dyspnea score 1 (n = 292)
Number of subjects: 3830
Study: 22964859

Group type: EXPERIMENTAL
Intervention: 1-minute rest interval (RI) during bench press
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 2-minute rest interval (RI) during bench press
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 3-minute rest interval (RI) during bench press
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: All RIs (1, 2, and 3 minutes)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Manipulation of RI length
Number of subjects: 22
Study: 20876217

Group type: EXPERIMENTAL
Intervention: SBIRT (Screening, Brief Intervention and Referral for Treatment)
Number of subjects: 1132

Group type: COMPARATOR
Intervention: Control (written handout)
Number of subjects: 1132
Study: 18574113

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Imiquimod 5%
Number of subjects: 80
Study: 15748956

Group type: EXPERIMENTAL
Intervention: IFN‐beta‐1a 44 mug SC tiw
Number of subjects: 15

Group type: COMPARATOR
Intervention: IFN‐beta‐1a 30 mug IM qw
Number of subjects: 15
Study: 12694346

Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering therapy with simvastatin and ezetimide
Number of subjects: 9000
Study: 10521634

Group type: EXPERIMENTAL
Intervention: EMG‐assisted model of spine loading
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Task asymmetry and weight lifted
Number of subjects: 12
Study: 8612386

Group type: EXPERIMENTAL
Intervention: Iron-ovotransferrin complex
Number of subjects: 0

Group type: COMPARATOR
Intervention: Iron-gluconate formulation
Number of subjects: 0
Study: 1992306

Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide (n = 7; maximal dose, 30 mg/kg/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Calcium carbonate (n = 10; dose range, 2.5 to 12 g/day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Aluminum hydroxide (n = 7)
Number of subjects: 17
Study: 6362210

Group type: EXPERIMENTAL
Intervention: Transfer factor (TF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 31864728

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 48
Study: 30683803

Group type: EXPERIMENTAL
Intervention: Peer-led social marketing intervention by adolescent creators (94 ACs, aged 12-14 years)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 375
Study: 28385939

Group type: EXPERIMENTAL
Intervention: Active ultrasound device (n = 32)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo ultrasound device (n = 30)
Number of subjects: 62
Study: 25985806

Group type: EXPERIMENTAL
Intervention: Tapentadol IR 43 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tapentadol IR 86 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morphine IR 30 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tapentadol IR 75-100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tapentadol IR 125-175 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tapentadol ER 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tapentadol ER 200 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxycodone CR 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25208357

Group type: EXPERIMENTAL
Intervention: Essential oil (EO) mouthrinse
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Cetylpyridinium chloride (CPC) mouthrinse
Number of subjects: 354

Group type: COMPARATOR
Intervention: Control (5% hydroalcohol solution)
Number of subjects: 354
Study: 22665834

Group type: EXPERIMENTAL
Intervention: Acute Care for Elders Unit
Number of subjects: 1632

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1632
Study: 19849720

Group type: EXPERIMENTAL
Intervention: Needle-free system (Sumavel DosePro)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Needle-based system (Imitrex STATdose System)
Number of subjects: 109
Study: 17323183

Group type: EXPERIMENTAL
Intervention: High Dose Etidronate (400 mg daily for 2 weeks followed by 10 weeks off treatment, repeated four times)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Low Dose Etidronate (200 mg daily)
Number of subjects: 414

Group type: COMPARATOR
Intervention: Control Group (1 microg alfacalcidol daily)
Number of subjects: 414
Study: 15231556

Group type: EXPERIMENTAL
Intervention: Computer-delivered CBT
Number of subjects: 274

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 274
Study: 10947691

Group type: EXPERIMENTAL
Intervention: Inhalational isodesox
Number of subjects: 112

Group type: COMPARATOR
Intervention: Intravenous fentanyl and midazolam
Number of subjects: 112
Study: 8629755

Group type: EXPERIMENTAL
Intervention: Integration of injury control information in a physics course
Number of subjects: 203
Study: 1631861

Group type: EXPERIMENTAL
Intervention: Creatine phosphate (10 mmol/L)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Plain cardioplegic solutions (control)
Number of subjects: 30
Study: 6708394

Group type: EXPERIMENTAL
Intervention: Moderate sodium restriction (80 mmol Na/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Combined low-sodium/high-potassium diet (80 mmol Na/120 mmol K)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Moderate sodium restriction or combined low-sodium/high-potassium diet
Number of subjects: 21

Group type: COMPARATOR
Intervention: Combined low-sodium/high-potassium diet
Number of subjects: 21
Study: 31514043

Group type: EXPERIMENTAL
Intervention: Transdiagnostic Behavior Therapy (TBT)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Behavioral Activation Treatment for Depression (BATD)
Number of subjects: 105
Study: 30203777

Group type: EXPERIMENTAL
Intervention: Radix astragali and Salvia miltiorrhiza injection
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (local massage and rehabilitation training)
Number of subjects: 600
Study: 27122141

Group type: EXPERIMENTAL
Intervention: CHILE Intervention
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (comparison group)
Number of subjects: 16
Study: 22475073

Group type: EXPERIMENTAL
Intervention: First-person narratives
Number of subjects: 500

Group type: COMPARATOR
Intervention: Third-person narratives
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Both narrative types
Number of subjects: 500
Study: 19847593

Group type: EXPERIMENTAL
Intervention: Anterolateral minimally-invasive incision
Number of subjects: 110

Group type: COMPARATOR
Intervention: Standard posterolateral incision
Number of subjects: 110
Study: 18452346

Group type: EXPERIMENTAL
Intervention: Olanzapine LAI 210 mg/2 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olanzapine LAI 300 mg/2 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olanzapine LAI 405 mg/4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15821652

Group type: COMPARATOR
Intervention: Warm‐Touch
Number of subjects: 90

Group type: COMPARATOR
Intervention: Thermamed SmartCare OP
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Allon 2001
Number of subjects: 90
Study: 12844377

Group type: EXPERIMENTAL
Intervention: Retinyl palmitate-containing toothpaste (1 mg/g)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo toothpaste
Number of subjects: 30
Study: 10893090

Group type: EXPERIMENTAL
Intervention: CPAP therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing CPAP usage
Number of subjects: 0
Study: 8850403

Group type: EXPERIMENTAL
Intervention: Intravenous propafenone, 1 to 2 mg/kg in a 10‐minute bolus, followed by an infusion of 420 mg in 24 hours.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous amiodarone, 2.5 to 5 mg/kg in a 10‐minute bolus followed by an infusion of 900 mg in 24 hours.
Number of subjects: 40
Study: 1507039

Group type: EXPERIMENTAL
Intervention: Delmopinol HCl 0.2%
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Chlorhexidine digluconate 0.2%
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Delmopinol HCl 0.2% and Chlorhexidine digluconate 0.2%
Number of subjects: 45
Study: 2931266

Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate glycol cream 0.05%
Number of subjects: 80

Group type: COMPARATOR
Intervention: Desoximetasone ointment 0.25%
Number of subjects: 80
Study: 31382822

Group type: EXPERIMENTAL
Intervention: Total Cholesterol (TC)
Number of subjects: 600000

Group type: EXPERIMENTAL
Intervention: Low-Density Lipoprotein Cholesterol (LDL-C)
Number of subjects: 600000

Group type: EXPERIMENTAL
Intervention: Triglycerides
Number of subjects: 600000

Group type: EXPERIMENTAL
Intervention: Apolipoprotein B (ApoB)
Number of subjects: 600000
Study: 29063516

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Fluconazole 100 mg every 12 h
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 26831173

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine administered extradurally
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine administered via femoral and transgluteal sciatic electrolocation-guided nerve block
Number of subjects: 22

Group type: COMPARATOR
Intervention: Comparison between the two groups using different loco-regional anaesthetic techniques
Number of subjects: 22
Study: 25439693

Group type: EXPERIMENTAL
Intervention: Adjuvant capecitabine plus oxaliplatin (8 cycles of oral capecitabine 1000 mg/m² twice daily on days 1-14 plus intravenous oxaliplatin 130 mg/m² on day 1 for 6 months)
Number of subjects: 1035

Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 1035

Group type: EXPERIMENTAL
Intervention: Adjuvant capecitabine plus oxaliplatin
Number of subjects: 1035
Study: 22608584

Group type: EXPERIMENTAL
Intervention: Bilateral iliohypogastric and ilioinguinal nerve blocks with 24 mL of 0.5% bupivacaine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 34
Study: 20581162

Group type: EXPERIMENTAL
Intervention: Oropharyngeal cavity spray of benzydamine hydrochloride (BH) and distilled water on the ET cuff (Group A)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Both oropharyngeal cavity and ET cuff received BH spray (Group B)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: ET cuff received BH spray, oropharyngeal cavity received distilled water (Group C)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Distilled water sprayed on both ET tube and oropharyngeal cavity (Group D)
Number of subjects: 380
Study: 18035203

Group type: EXPERIMENTAL
Intervention: Test formulation (generic soft-gelatin capsule of cyclosporin A microemulsion, 100 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Reference formulation (branded soft-gelatin capsule of cyclosporin A microemulsion, 100 mg)
Number of subjects: 36
Study: 19253780

Group type: COMPARATOR
Intervention: Hearing aids in omnidirectional microphone mode
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hearing aids with noise reduction (NR) algorithm and directional microphones
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Amplification (hearing aids)
Number of subjects: 14
Study: 15232503

Group type: EXPERIMENTAL
Intervention: Pulsatile flow
Number of subjects: 19

Group type: COMPARATOR
Intervention: Non-pulsatile flow
Number of subjects: 19